// App-Quantinova.ai

3133 : Effects of Ibrutinib on Metabolic Alterations and Micro-Environmental Signalling in Chronic Lymphocytic Leukaemia

Researchers

Presenter

  • Zhenghao Chen

Principal Investigators

  • Gaspard Cretenet

  • Beatriz Valle-Argos

  • Francesco Forconi

  • Arnon P. Kater

  • Graham Packham

  • Eric Eldering

Medical Centers

  • Department of Experimental Immunology, University of Amsterdam, Amsterdam, Netherlands

  • Amsterdam Institute of Infection and Immunity, Cancer Center Amsterdam, and Lymphoma and Myeloma Center (LYMMCARE), Amsterdam, Netherlands

  • Cancer Research UK Centre, Cancer Sciences Division, University of Southampton, Southampton, United Kingdom

  • Dept of Haematology, Southampton Univ Hospt, Southampton, United Kingdom

  • Department of Radiation Oncology, Academic Medical Center, Amsterdam, Netherlands

Locations

  • Netherlands

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Chronic Lymphocytic Leukemia

Biomarkers

  • Breakpoint Cluster Region

  • Cluster of Differentiation 40

  • Cluster of differentiation 95

Drug/Treatment

  • Ibrutinib

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved